bioRxivPharmacology & Toxicology
Efficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models
Abstract
Quantitative systems pharmacology models mechanistically describe a biological system and the effect of drug treatment on system behavior. Because these models rarely are identifiable from the available data, the uncertainty in physiological parameters may be sampled to create alternative parameterizations of the model, sometimes termed Virtual Patients. In order to reproduce the statistics of a clinical population, Virtual Patients are often weighted to form a Virtual Population that reflects the baseline characteristics of the clinical cohort. Here we introduce a novel technique to efficiently generate Virtual Patients and, from this ensemble, demonstrate how to select a Virtual Population that matches the observed data without the need for weighting. This approach improves confidence in model predictions by mitigating the risk that spurious Virtual Patients become over-represented in Virtual Populations.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Improving the Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models
T. R. Rieger, R. J. Allen, … C. J. Musante·bioRxiv·Jan 18, 2018
- Generation of virtual populations for quantitative systems pharmacology through advanced sampling methods
Miriam Schirru, Tristan Brier, … Fahima Nekka·Bulletin of Mathematical BiologyPeer-reviewed·Oct 17, 2025
- A surrogate workflow for virtual population development: designing an amenable proxy for a hypothesis-test inspired nonlinear goodness-of-fit
Lu Cheng Huang, Yinbo Chen, … Brian James Schmidt·The AAPS JournalPeer-reviewed·Oct 13, 2025
- Approaches to generating virtual patient cohorts with applications in oncology
A. Surendran, J. L. Sauteur-Robitaille, … M. Craig·bioRxiv·May 24, 2022
- Replicate Engineered Virtual Patient Populations as Surrogates for Real Patient-Level Data
Francis J. Alenghat·bioRxiv·Feb 19, 2020
- Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition
Hanwen Wang, Theinmozhi Arulraj, … Aleksander S. Popel·npj Precision OncologyPeer-reviewed·Jun 8, 2023